erlotinib hydrochloride has been researched along with Staphylococcal Infections in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botella-Estrada, R; Escutia-Muñoz, B; Rodríguez-Serna, M; Sahuquillo-Torralba, A | 1 |
Del Giudice, P; Delord, JP; Hubiche, T; Roché, H; Sibaud, V; Tournier, E | 1 |
Kaley, K; Li, J; Peccerillo, J; Saif, MW | 1 |
Chu, DS; Johnson, KS; Levin, F | 1 |
Amitay-Laish, I; David, M; Stemmer, SM | 1 |
Gipps, M; Goldberg, A; Grenader, T | 1 |
6 other study(ies) available for erlotinib hydrochloride and Staphylococcal Infections
Article | Year |
---|---|
Folliculitis Decalvans Caused by Bacterial Superinfection Secondary to Erlotinib.
Topics: Aged; Antineoplastic Agents; Erlotinib Hydrochloride; Fatal Outcome; Female; Folliculitis; Humans; Staphylococcal Infections; Staphylococcus aureus; Superinfection | 2018 |
Late epidermal growth factor receptor inhibitor-related papulopustular rash: a distinct clinical entity.
Topics: Adult; Aged; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pruritus; Quinazolines; Skin Diseases, Papulosquamous; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancer.
Topics: Bacteremia; Drug Eruptions; Erlotinib Hydrochloride; Female; Humans; Middle Aged; Pancreatic Neoplasms; Protein Kinase Inhibitors; Quinazolines; Skin; Staphylococcal Infections; Staphylococcus aureus | 2009 |
Persistent corneal epithelial defect associated with erlotinib treatment.
Topics: Aged; Cataract Extraction; Corneal Diseases; Epithelium, Corneal; Erlotinib Hydrochloride; Female; Humans; Keratitis; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Staphylococcal Infections; Staphylococcus epidermidis | 2009 |
Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Coagulase; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Staphylococcal Infections | 2010 |
Staphylococcus aureus bacteremia secondary to severe erlotinib skin toxicity.
Topics: Bacteremia; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines; Skin; Staphylococcal Infections | 2008 |